LABA/LAMA versus LABA/ICS fixed-dose combinations in the prevention of COPD exacerbations: a modeling analysis of literature aggregate data

被引：0
|
作者：
Yiwen Gong
Zichao Sui
Yinghua Lv
Qingshan Zheng
Lujin Li
机构：
[1] University of Traditional Chinese Medicine,Center for Drug Clinical Evaluation Shanghai
来源：
European Journal of Clinical Pharmacology | 2023年 / 79卷
关键词：
Chronic obstructive pulmonary disease; LABA/LAMA fixed-dose combinations; LABA/ICS fixed-dose combinations; COPD exacerbations; Model-based meta-analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
页码：1321 / 1332
页数：11
相关论文
共 50 条
  • [21] Differences in Pulmonary Function Improvement after Once-Daily LABA/LAMA Fixed-Dose Combinations in Patients with COPD
    Huang, Wei-Chun
    Chen, Chih-Yu
    Liao, Wei-Chih
    Wu, Biing-Ru
    Chen, Wei-Chun
    Tu, Chih-Yen
    Chen, Chia-Hung
    Cheng, Wen-Chien
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (23)
  • [22] LAMA/LABA Fixed Combinations for COPD Management: A Systematic Comparative Review
    Rogliani, P.
    Braido, F.
    Calzetta, L.
    Cazzola, M.
    Clini, E. M.
    Pelaia, G.
    Rossi, A.
    Scichilone, N. A.
    Di Marco, F.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [23] GP survey on how to incorporate LABA/LAMA fixed dose combinations (FDC) in their COPD patients
    Kaplan, Alan
    Hill, David
    Cyr, Marie-Andree
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [24] Evaluation of Time-to-Triple Therapy in Patients Diagnosed with COPD Initiating Maintenance Therapy with a Fixed-Dose Combination of LAMA/LABA Versus ICS/LABA Within a Large US Health Insurer Database
    Moretz, C.
    Bengtson, L. G. S.
    Sharpsten, L.
    Le, L.
    Koep, E.
    Tong, J.
    Hahn, B.
    Stanford, R. H.
    Asmus, M. J.
    Ray, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [25] The Role of ICS/LABA Fixed-Dose Combinations in the Treatment of Asthma and COPD: Bioequivalence of a Generic Fluticasone Propionate-Salmeterol Device
    Tashkin, Donald P.
    Ohar, Jill A.
    Koltun, Arkady
    Allan, Richard
    Ward, Jonathan K.
    PULMONARY MEDICINE, 2021, 2021
  • [26] Population Pharmacokinetic Analysis of Single Inhaler Triple Therapy (ICS/LAMA/LABA) Versus Dual Therapy (LAMA/LABA and ICS/LABA) in Patients with Symptomatic COPD: Combined Results from Three Phase III Trials
    Mehta, R.
    Farrell, C.
    Kilbride, S.
    Zhu, C.
    Brooks, J.
    Barnhart, F.
    Birk, R.
    Lipson, D. A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [27] Impact of ICS/LABA and LABA/LAMA FDCs on functional and clinical outcomes in COPD: A network meta-analysis
    Calzetta, Luigino
    Di Marco, Fabiano
    Blasi, Francesco
    Cazzola, Mario
    Centanni, Stefano
    Micheletto, Claudio
    Rossi, Andrea
    Rogliani, Paola
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2019, 59
  • [28] Comparative efficacy of inhaled medications (ICS/LABA, LAMA, LAMA/LABA and SAMA) for COPD: a systematic review and network meta-analysis
    Aziz, Mohamed Ismail Abdul
    Tan, Ling Eng
    Wu, David Bin-Chia
    Pearce, Fiona
    Chua, Gerald Seng Wee
    Lin, Liang
    Tan, Ping-Tee
    Ng, Kwong
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2018, 13 : 3203 - 3231
  • [29] Pharmacology of novel treatments for COPD: are fixed dose combination LABA/LAMA synergistic?
    Spina, Domenico
    EUROPEAN CLINICAL RESPIRATORY JOURNAL, 2015, 2 (01):
  • [30] Switch from LABA plus ICS to a LABA/LAMA combination in symptomatic women with COPD - an analysis of the observational DACCORD study
    Kardos, Peter
    Buhl, Roland
    Criee, Carl-Peter
    Lossi, Nadine
    Vogelmeier, Claus
    Worth, Heinrich
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
12345